GMP CAPA Non-Compliance Fines
Definition
Inadequate CAPA management in deviation investigations triggers TGA GMP compliance failures, resulting in batch rejections, rework, and inspection deficiencies.
Key Findings
- Financial Impact: AUD 20,000-100,000 per GMP violation (batch rejection + rework costs); typical 2-5% production loss from deviations[3][6]
- Frequency: Per TGA inspection or deviation event
- Root Cause: Manual CAPA processes fail root cause analysis and timely closure, violating PIC/S standards
Why This Matters
The Pitch: Pharmaceutical players in Australia waste AUD 50,000+ annually on CAPA rework and GMP violations. Automation of deviation investigation eliminates this risk.
Affected Stakeholders
Quality Manager, Manufacturing Head, Compliance Officer
Deep Analysis (Premium)
Financial Impact
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Current Workarounds
Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.
Get Solutions for This Problem
Full report with actionable solutions
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
CAPA Rework and Investigation Overheads
TGA Non-Compliance Fines
Cost of Poor Quality from Trending Failures
Idle Capacity from Review Delays
Kosten durch TGA-GMP-Abweichungen bei Änderungsdokumentation
Produktivitätsverlust durch manuelle Änderungsdokumentation
Request Deep Analysis
🇦🇺 Be first to access this market's intelligence